YCBD (cbdMD, Inc.) Earnings per share growth rate in current year

Official company branding of cbdMD, Inc. (YCBD)

A steady inflow of funds from retail CBD product sales supports the operational resilience of cbdMD, Inc. (YCBD). This annual EPS growth chart visualizes this trend, where 69.50 describes the current status of the metric. The positive trend is based on the application of advanced component extraction methods, although logistics costs and raw material supply disruptions from Asia create certain pressure on the bottom line.

YCBD (cbdMD Corp) Earnings growth in current year history from 07/04/2022 to 11/13/2026
Finished products of cbdMD Corp

Annual EPS growth measures the dynamics of net income per share, allowing investors to identify business value inflection points between quarterly reports. Amid trade barriers and rising logistics costs for cbdMD, Inc. (YCBD), the year-over-year percentage change in EPS reflects the resilience of margins against geopolitical pressure. Analysis of this metric determines whether the business is capable of generating alpha despite inflation-driven declines in demand.

Direct competitors

Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal)|PRGO - Net earnings per share growth this year|Alvotech Corp - Earnings growth in current year|LQDA: Earnings per share growth in current year|GLPG: Earnings growth in current year|Earnings per share growth this year ANIP|Earnings per share growth in current year MannKind|Net earnings per share growth this year Amphastar Pharmaceuticals Inc (AMPH)|Earnings growth in current year PCRX|ARS Corp - Earnings per share growth this year|Theravance Biopharma - Net earnings per share growth this year|Earnings per share increase in current year AQST|scPharma - Earnings growth in current year|Expected net earnings per share growth this year Tectonic Therapeutic, Inc. TECX|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|Earnings per share growth this year SXTC|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth in current year|Net earnings per share growth this year bioharvest.com (BHST)|Net earnings per share growth this year EXOZ (eXoZymes)|Expected net earnings per share growth this year oramed.com|Entera Bio - Net earnings per share growth this year|MindWalk Therapeutics (HYFT) - Earnings per share growth rate in current year|ABVC BioPharma - Earnings growth in current year|cumberlandpharma.com (CPIX) - Net earnings per share growth this year|QNTM: Earnings growth in current year|FGEN (FibroGen Inc) - Earnings per share growth in current year|TELO (Telomir Pharma) - Earnings growth in current year|Earnings per share growth this year RANI (Rani Therapeutics Inc)|Earnings per share growth in current year Synergy CHC Corp (SNYR)|RLYB: Earnings per share trend in current year|Earnings growth in current year LEXX (Lexaria Bioscience Corp.)|Earnings per share increase in current year PULM|Pheton - Earnings growth in current year|APM - Earnings growth in current year|Lyra Therapeutics, Inc. (LYRA) - Earnings per share growth in current year|Impact BioMedical, Inc. - Earnings per share increase in current year|Earnings per share growth in current year TNF Pharmaceuticals Inc.|Net earnings per share growth this year PainReform Ltd (PRFX)|Earnings growth in current year CYTO|Earnings growth in current year Lipella Pharma (LIPO)|OptiNose, Inc. - Net earnings per share growth this year|Earnings per share increase in current year PIRS|PROC - Earnings per share growth in current year|Earnings per share growth rate in current year Petros Pharmaceuticals Inc|QLI (Qilian International Holding Group Limited) - Net earnings per share growth this year|SLRN: Net earnings per one share growth for the current year|TFFP (TFF Pharmaceuticals) - Earnings growth in current year